Kave Shams

University of Leeds — United Kingdom

Immunology and Microbiology · Life Sciences

12h-index511citations63works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(19), Sympathectomy and Hyperhidrosis Treatments(9), Dermatology and Skin Diseases(6), Autoimmune Bullous Skin Diseases(6), Viral Infections and Vectors(6)

Publications63 total

Sand fly saliva reprograms skin fibroblasts to enhance arbovirus infection
iScience·2025Open Access
MON-652 Rhabdomyolysis Secondary To Refractory Hemichorea In The Setting Of Nonketotic Hyperglycemia
Journal of the Endocrine Society·2025Open Access
Improving the delivery of multi-specialty care: the rise of the combined clinic service
Lara D. Veeken·2025Open Access
P116 Patient characteristics of biologic-experienced and biologic-naive patients with chronic plaque psoriasis receiving bimekizumab
British Journal of Dermatology·2025Open Access
P054 Safety outcomes with GP2015 (etanercept biosimilar) in psoriasis: real-world evidence from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
British Journal of Dermatology·2025Open Access
P100 Effectiveness of risankizumab in biologic-naive and biologic-experienced patients with psoriasis: real-world data from the BADBIR registry
British Journal of Dermatology·2025Open Access
Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)
British Journal of Dermatology·2025· 3 citedOpen Access
POS0838 REFERRALS TO DEDICATED PSORIATIC DISEASE TRIAGE CLINIC RESULT IN SIMILAR RATE OF NEWLY DIAGNOSED PSORIATIC ARTHRITIS, IRRESPECTIVE OF REFERRAL ROUTE
Annals of the Rheumatic Diseases·2025Open Access
High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Dermatology and Therapy·2025Open Access
Risk stratification of childhood infection using host markers of immune and endothelial activation: a multi-country prospective cohort study in Asia (Spot Sepsis)
2025Open Access
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral route
Rheumatology Advances in Practice·2025Open Access
Derivation and validation of prognostic models for the risk stratification of childhood infection: a multi-country prospective cohort study in Asia (Spot-Sepsis)
2025Open Access
51067 Beyond Race-Ethnicity: Fitzpatrick Skin Type Analysis Highlights Unmet Needs and Differing Treatment Patterns in Psoriasis among the Conventional Systemics Cohort of British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Journal of the American Academy of Dermatology·2024
High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study
British Journal of Dermatology·2024· 2 citedOpen Access
O12 Community Psoriasis: Phenotype and Comorbidity Assessment (COPPACA): an observational study of the prevalence, phenotype and health burden of psoriasis in the community
British Journal of Dermatology·2024Open Access
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group
Journal of Investigative Dermatology·2023· 2 citedOpen Access
43315 Improvements in Skin Clearance and Patient-Reported Outcomes were Greater with Guselkumab Compared with Ustekinumab Among Patients with Persistent Mild Psoriasis After 16- Weeks of Treatment with Ustekinumab
Journal of the American Academy of Dermatology·2023
P69 Baseline characteristics of patients with physician-diagnosed hidradenitis suppurativa: results from a retrospective observational study using data from the Clinical Practice Research Datalink database
British Journal of Dermatology·2023Open Access
P89 Real-world effectiveness of guselkumab in patients with psoriasis with and without concomitant psoriatic arthritis: retrospective data from the British Association of Dermatologists Biologics and Immunomodulators Register
British Journal of Dermatology·2023Open Access
P97 Risankizumab real-world effectiveness in UK clinical practice: results from the BADBIR registry
British Journal of Dermatology·2023· 1 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Clive S. McKimmie(6), Philip Laws(6), Helena Marzo‐Ortega(6), Gerard J. Graham(5), Daniella Lefteri(4), Steven R. Bryden(4), Marieke Pingen(4), Andres Merits(4), Emilie Pondeville(4), Margus Varjak(3), Gina M. Kavanagh(3), A. David Burden(3), J.L. Carretero Sastre(3), Jaume Ferrer(3), Eduard Monsó Molas(3), I. Pascal Martínez(3), E. Rodríguez Becerra(3), Francisco Rodríguez Panadero(3), Ramzi Ajjan(3), E. Hensor(3)